Golden Lee Scott

Insider profile

Performance

Overall performance
3.3

Performance over holding periods
3.3
30 days 90 days 120 days
Average return -0% 8.2% 15.1%
Success rate 67% 68% 82%
Transactions
13 0% Buy
34 71% Buy
47 69% Buy
Golden Lee Scott's trades of PTC Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-04-06 2026-04-02 S Sale
19,681 -20.9%
51.86
US$3,240,466
19,681 -20.9% 51.86 US$3,240,466
2026-04-02 2026-04-02 PrS Proposed sale
56,926
143.40
US$3,425,427
56,926 143.40 US$3,425,427
2026-03-09 2026-03-05 PlS Planned sale
40,165 -1.2%
67.58
US$1,619,162
40,165 -1.2% 67.58 US$1,619,162
2026-03-05 2026-03-05 PrS Proposed sale
10,000
63.38
US$633,800
10,000 63.38 US$633,800
2026-02-20 2026-02-18 S Sale
2,484 -2.7%
69.36
US$172,290
2,484 -2.7% 69.36 US$172,290
2026-02-18 2026-02-18 PrS Proposed sale
2,484
69.36
US$172,282
2,484 69.36 US$172,282
2026-01-12 2026-01-08 S Sale
866 -0.9%
76.45
US$66,206
866 -0.9% 76.45 US$66,206
2026-01-08 2026-01-08 PrS Proposed sale
866
76.45
US$66,205
866 76.45 US$66,205
2026-01-08 2026-01-07 S Sale
642 -0.7%
77.48
US$49,742
642 -0.7% 77.48 US$49,742
2026-01-07 2026-01-07 PrS Proposed sale
642
77.48
US$49,745
642 77.48 US$49,745
2026-01-08 2026-01-06 S Sale
1,340 -1.4%
76.95
US$103,113
1,340 -1.4% 76.95 US$103,113
2026-01-06 2026-01-06 PrS Proposed sale
1,340
76.95
US$103,110
1,340 76.95 US$103,110
2025-04-04 2025-04-02 S Sale
897 -1.2%
46.95
US$42,114
897 -1.2% 46.95 US$42,114
2025-04-02 2025-04-02 PrS Proposed sale
897
46.95
US$42,117
897 46.95 US$42,117
2025-02-21 2025-02-20 S Sale
962 -1.2%
50.12
US$48,219
962 -1.2% 50.12 US$48,219
2025-02-20 2025-02-20 PrS Proposed sale
962
50.12
US$48,219
962 50.12 US$48,219
2025-02-21 2025-02-19 S Sale
795 -1.0%
50.10
US$39,826
795 -1.0% 50.10 US$39,826
2025-02-19 2025-02-19 PrS Proposed sale
795
50.10
US$39,827
795 50.10 US$39,827
2025-01-10 2025-01-08 S Sale
1,198 -1.5%
44.50
US$53,311
1,198 -1.5% 44.50 US$53,311
2025-01-08 2025-01-08 PrS Proposed sale
1,198
44.50
US$53,311
1,198 44.50 US$53,311
2025-01-10 2025-01-07 S Sale
810 -1.0%
45.34
US$36,725
810 -1.0% 45.34 US$36,725
2025-01-07 2025-01-07 PrS Proposed sale
810
45.34
US$36,723
810 45.34 US$36,723
2024-05-08 2024-05-07 S Sale
175 -0.3%
32.82
US$5,744
175 -0.3% 32.82 US$5,744
2024-05-07 2024-05-07 PrS Proposed sale
175
32.82
US$5,744
175 32.82 US$5,744
2024-04-04 2024-04-02 S Sale
526 -0.9%
28.37
US$14,923
526 -0.9% 28.37 US$14,923
2024-04-02 2024-04-02 PrS Proposed sale
526
28.37
US$14,922
526 28.37 US$14,922
2024-01-10 2024-01-09 S Sale
1,225 -3.1%
29.01
US$35,543
1,225 -3.1% 29.01 US$35,543
2024-01-09 2024-01-09 PrS Proposed sale
1,225
29.01
US$35,543
1,225 29.01 US$35,543
2024-01-10 2024-01-08 PlS Planned sale
775 -1.9%
28.64
US$22,196
775 -1.9% 28.64 US$22,196
2024-01-08 2024-01-08 PrS Proposed sale
775
28.64
US$22,196
775 28.64 US$22,196